-
Product Insights
NewC-C Chemokine Receptor Type 8 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 8 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 8 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Toxicology, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Opioid Induced Side Effects, Alzheimer's Disease, and Neuropathic Pain (Neuralgia). It also...
-
Product Insights
NewProstaglandin E2 Receptor EP4 Subtype – Drugs In Development, 2024
The Prostaglandin E2 Receptor EP4 Subtype pipeline drugs market research report outlays comprehensive information on the Prostaglandin E2 Receptor EP4 Subtype targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Musculoskeletal Disorders, and Central Nervous System which include indications of Colorectal Cancer, Solid Tumor, Autoimmune Disorders, Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Pain, and Cancer Pain. It also...
-
Product Insights
NewPlatelet Derived Growth Factor Receptor Alpha – Drugs In Development, 2024
The Platelet Derived Growth Factor Receptor Alpha pipeline drugs market research report outlays comprehensive information on the Platelet Derived Growth Factor Receptor Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Gastrointestinal, and Infectious Disease which include indications of Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Idiopathic Pulmonary Fibrosis, Interstitial Lung Fibrosis, Systemic Mastocytosis, Coronavirus Disease...
-
Product Insights
NewPoly [ADP Ribose] Polymerase 2 – Drugs In Development, 2024
The Poly [ADP Ribose] Polymerase 2 pipeline drugs market research report outlays comprehensive information on the Poly [ADP Ribose] Polymerase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, and Undisclosed which include indications of Ovarian Cancer, Solid Tumor, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Pneumonia, and Unspecified. It also reviews key...
-
Product Insights
NewSolute Carrier Family 22 Member 12 – Drugs In Development, 2024
The Solute Carrier Family 22 Member 12 pipeline drugs market research report outlays comprehensive information on the Solute Carrier Family 22 Member 12 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Metabolic Disorders, Genito Urinary System, and Gastrointestinal which include indications of Gouty Arthritis (Gout), Hyperuricemia, Chronic Kidney Disease (Chronic Renal Failure), Metabolic Dysfunction-Associated Steatohepatitis...
-
Product Insights
NewE3 Ubiquitin Protein Ligase Mdm2 – Drugs In Development, 2024
The E3 Ubiquitin Protein Ligase Mdm2 pipeline drugs market research report outlays comprehensive information on the E3 Ubiquitin Protein Ligase Mdm2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Ophthalmology which include indications of Solid Tumor, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), and Proliferative Vitreoretinopathy (PVR). It also reviews key players involved in E3...
-
Product Insights
NewTGF Beta Receptor Type 1 – Drugs In Development, 2024
The TGF Beta Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the TGF Beta Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Gastrointestinal which include indications of Solid Tumor, Esophageal Cancer, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Wounds, Keloids, Crohn's Disease (Regional Enteritis), and Oral Mucositis. It...
-
Product Insights
New5-Hydroxytryptamine Receptor 3 – Drugs In Development, 2024
The 5-Hydroxytryptamine Receptor 3 pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Toxicology, Central Nervous System, and Immunology which include indications of Post Operative Nausea And Vomiting, Irritable Bowel Syndrome, Chemotherapy Induced Nausea and Vomiting, Radiation Induced Nausea and Vomiting (RINV), Parkinson's Disease,...
-
Product Insights
NewInterleukin 2 Receptor Subunit Alpha – Drugs In Development, 2024
The Interleukin 2 Receptor Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Interleukin 2 Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Cardiovascular which include indications of Solid Tumor, Melanoma, Systemic Lupus Erythematosus, Autoimmune Disorders, Atopic Dermatitis (Atopic Eczema), Alopecia Areata, Pulmonary Arterial Hypertension, and Stroke....
-
Product Insights
NewADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 – Drugs In Development, 2024
The ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 pipeline drugs market research report outlays comprehensive information on the ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Hematological Disorders which include indications of Multiple Myeloma (Kahler Disease), Relapsed Multiple Myeloma, Systemic Lupus Erythematosus, Unspecified Immunological Disorders,...